Download Full Text (7.3 MB)
- Specialized Training and Techniques of Pathologists Lead to Targeted Therapies
- Protocols: Studies Examine High-Dose Chemotherapy for Breast Cancer
- High-Dose Chemotherapy for Breast Cancer: Completion of Clinical Trials Necessary
- DiaLog: Many Specialties, One Goal, by Janet M. Bruner, MD, Chairman, Department of Pathology
- House Call: Support Groups Offer Patients a Helping Hand
- Study Reveals Types of Diagnostic Errors and Their Costs
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
Glassman, Armand B.; Rahman, Saba; Bruner, Janet M., 1949-; Ueno, Naoto T.; Hontiveros, Rosemarie; Rondon, Gabriela; Konoplev, Sergej; Klausner, Richard; Antineoplastic Agents; Cytogenetics; Cytogenetic Analysis; Oncogene Proteins v-erbB; Genes, erbB-2; Antibodies, Monoclonal; Molecular Biology; Leukemia; Lymphoma; Leukemia, Myeloid, Acute; Gemtuzumab; Rituximab; In Situ Hybridization, Fluorescence; Chromosome Aberrations; Genetic Markers; Pathologists; Immunophenotyping; Sentinel Lymph Node Biopsy; Diagnostic Errors; Neoplasm Staging; Breast Neoplasms; Melanoma; Bone Neoplasms; Biopsy, Fine-Needle; Hematopoietic Stem Cell Transplantation; Clinical Trials as Topic; Carmustine; Thiotepa; Self-Help Groups.
History of Science, Technology, and Medicine | Oncology
Hosemann, Sunni; Wright, Kerry L.; and Bruner, Janet M. MD, "OncoLog, Volume 46, Number 02, February 2001" (2001). OncoLog MD Anderson's Report to Physicians (All issues). 99.
Conditions Governing Access